Literature DB >> 11476008

[Emergency calls in the Samu system].

G Barrier1.   

Abstract

The French emergency medical system is public and medical. Named Samu, it is almost entirely managed by anesthesiologists specially trained for emergency medical assistance and advanced medical support. The system comprises a reception and dispatching center for emergency calls, directly connected to police and firemen, but assuring patient confidentiality. This fixed center is managing mobile units which are Medical Intensive Care Ambulances (MICA named Smur in France). The Samu's mission consists in performing urgent individual medical assistance and also medical services for treatment of mass casualties. It is also to find adequate hospital units for the patients, to perform medical transport and to be a consultant for general practitioners in emergency.

Entities:  

Mesh:

Year:  2001        PMID: 11476008     DOI: 10.1016/s0764-4469(01)01334-8

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  3 in total

1.  Management of acute allergic reactions by dispatching physicians in a Medical Emergency Dispatch Centre.

Authors:  Hélène Godet-Mardirossian; Nathalie-Sybille Goddet; François Dolveck; Michel Baer; Dominique Fletcher; Alexis Descatha
Journal:  Emerg Med J       Date:  2010-10-20       Impact factor: 2.740

2.  Validation of the Computerized Pediatric Triage Tool, pediaTRI, in the Pediatric Emergency Department of Lenval Children's Hospital in Nice: A Cross-Sectional Observational Study.

Authors:  Antoine Tran; Petri Valo; Camille Rouvier; Emmanuel Dos Ramos; Emma Freyssinet; Emma Baranton; Olivier Haas; Hervé Haas; Christian Pradier; Stéphanie Gentile
Journal:  Front Pediatr       Date:  2022-04-26       Impact factor: 3.569

3.  Trends of pre-hospital emergency medical services activity over 10 years: a population-based registry analysis.

Authors:  Valérie Pittet; Bernard Burnand; Bertrand Yersin; Pierre-Nicolas Carron
Journal:  BMC Health Serv Res       Date:  2014-09-10       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.